Reduced Protein C Activity Might be Associated With Progression of Peripheral Arterial Disease

Abstract

We evaluated the effect of reduced activities of protein C (PC) and protein S (PS) on the progression of peripheral arterial disease (PAD). We measured PC and PS activities in 106 patients with PAD and 44 patients with abdominal aortic aneurysm (AAA) in the same period. The incidences of PC deficiency in PAD and AAA were 4.7% and 4.5%, respectively, and those of PS were 14.1% and 11.4%, respectively; these incidences were much higher than those in the normal population. The PC and PS activities were significantly lower in patients having critical limb ischemia (CLI) than in patients with intermittent claudication. In particular, lower PC activity and female gender were determinant factors of CLI in multivariate logistic regression analysis. We suggest that PC deficiency is an independent predictor for the progression of CLI.

Keywords

peripheral arterial disease abdominal aortic aneurysm critical limb ischemia protein C protein S hypercoagulability

Get full access to this article

View all access options for this article.

References

Komai

Juri

. Impact of reduced endogenous anti-coagulation protein activity on vascular events of peripheral arterial disease. Int Angiol. 2009;28 (2):138–143.

Norgren

Hiatt

Dormandy

Nehler

Harris

Fowkes

; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45 (suppl S):S5–S67.

Sakata

Kario

Katayama

Matsuyama

Kato

Miyata

. Studies on congenital protein C deficiency in Japanese: prevalence, genetic analysis, and relevance to the onset of arterial occlusive diseases. Semin Thromb Hemost. 2000;26 (1):11–16.

Suehisa

Nomura

Kawasaki

Kanakura

. Frequency of natural coagulation inhibitor (antithrombin III, protein C and protein S) deficiencies in Japanese patients with spontaneous deep vein thrombosis. Blood Coagul Fibrinolysis. 2001;12 (2):95–99.

Nomura

Suehisa

Kawasaki

Okada

. Frequency of protein S deficiency in general Japanese population. Thromb Res. 2000;100 (5):367–371.

de Moerloose

Boehlen

. Inherited thrombophilia in arterial disease: a selective review. Semin Hematol. 2007;44 (2):106–113.

Kölbel

Goncalves

Dias

Strandberg

Acosta

Gottsäter

. Coagulation activation and ultrasound characteristics in patients with carotid artery disease. Thromb Res. 2010;125 (2):171–177.

Mota

de Castro Santos

Lima e Silva

de Carvalho Schachnik

deOliveira Sousa

das Graças Carvalho

. Hypercoagulability markers in patients with peripheral arterial disease: association to ankle-brachial index. Angiology. 2009;60 (5):529–535.

Gremmel

Koppensteiner

Panzer

. Residual thrombin generation potential is inversely linked to the occurrence of atherothrombotic events in patients with peripheral arterial disease. Eur J Clin Invest. 2014;44 (3):319–324.

10.

Vig

Chitolie

Bevan

Dormandy

Thompson

Halliday

. The prevalence of thrombophilia in patients with symptomatic peripheral vascular disease. Br J Surg. 2006;93 (5):577–581.

11.

Vig

Chitolie

Sleight

Bevan

Dormandy

Thompson

. Prevalence and risk of thrombophilia defects in vascular patients. Eur J Vasc Endovasc Surg. 2004;28 (2):124–131.

12.

Leng

Lee

Fowkes

. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1996;25 (6):1172–1181.

13.

Kölbel

Strandberg

Mattiasson

Stenflo

Lindblad

. Activated protein C-protein C inhibitor complex: a new biological marker for aortic aneurysms. J Vasc Surg. 2006;43 (5):935–939.

14.

Zarrouk

Keshavarz

Lindblad

Gottsäter

. APC-PCI complex levels for screening of AAA in patients with peripheral atherosclerosis. J Thromb Thrombolysis. 2013;36 (4):495–500.

15.

Gabazza

Takeya

Deguchi

. Protein C activation in NIDDM patients. Diabetologia. 1996;39 (12):1455–1461.